NCT05694715 2026-03-17Combination Therapy in Cancers With Mutations in DNA Repair GenesUniversity of California, San FranciscoPhase 1 Recruiting24 enrolled
NCT01657591 2023-01-19Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed21 enrolled